Salmonella spvC gene suppresses macrophage/neutrophil antibacterial defense mediated by gasdermin D
Objective Salmonella enterica serovar Typhimurium (S. Typhimurium) is a representative model organism for investigating host–pathogen interactions. It was reported that S. Typhimurium spvC gene alleviated intestinal inflammation to aggravate systemic infection, while the precise mechanisms remain unclear. In this study, the influence of spvC on the antibacterial defense of macrophage/neutrophil mediated by gasdermin D (GSDMD) was investigated. Methods Mouse macrophage-like cell lines J774A.1 and RAW264.7, neutrophil-like cells derived from HL-60 cells (human promyletic leukemia cell lines) were infected with S. Typhimurium wild type, spvC deletion and complemented strains. Cell death was evaluated by LDH release and Annexin V-FITC/PI staining. Macrophage pyroptosis and neutrophil NETosis were detected by western blotting, live cell imaging and ELISA. Flow cytometry was used to assess the impact of spvC on macrophage-neutrophil cooperation in macrophage (dTHP-1)-neutrophil (dHL-60) co-culture model pretreated with GSDMD inhibitor disulfiram. Wild-type and Gsdmd−/− C57BL/6J mice were utilized for in vivo assay. The degree of phagocytes infiltration and inflammation were analyzed by immunofluorescence and transmission electron microscopy. Results Here we find that spvC inhibits pyroptosis in macrophages via Caspase-1/Caspase-11 dependent canonical and non-canonical pathways, and restrains neutrophil extracellular traps extrusion in GSDMD-dependent manner. Moreover, spvC could ameliorate macrophages/neutrophils infiltration and cooperation in the inflammatory response mediated by GSDMD to combat Salmonella infection. Conclusions Our findings highlight the antibacterial activity of GSDMD in phagocytes and reveal a novel pathogenic mechanism employed by spvC to counteract this host defense, which may shed new light on designing effective therapeutics to control S. Typhimurium infection..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Inflammation research - 73(2023), 1 vom: 23. Dez., Seite 19-33 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhou, Liting [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s00011-023-01818-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR054317800 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR054317800 | ||
| 003 | DE-627 | ||
| 005 | 20240110064631.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240110s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00011-023-01818-9 |2 doi | |
| 035 | |a (DE-627)SPR054317800 | ||
| 035 | |a (SPR)s00011-023-01818-9-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhou, Liting |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Salmonella spvC gene suppresses macrophage/neutrophil antibacterial defense mediated by gasdermin D |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Objective Salmonella enterica serovar Typhimurium (S. Typhimurium) is a representative model organism for investigating host–pathogen interactions. It was reported that S. Typhimurium spvC gene alleviated intestinal inflammation to aggravate systemic infection, while the precise mechanisms remain unclear. In this study, the influence of spvC on the antibacterial defense of macrophage/neutrophil mediated by gasdermin D (GSDMD) was investigated. Methods Mouse macrophage-like cell lines J774A.1 and RAW264.7, neutrophil-like cells derived from HL-60 cells (human promyletic leukemia cell lines) were infected with S. Typhimurium wild type, spvC deletion and complemented strains. Cell death was evaluated by LDH release and Annexin V-FITC/PI staining. Macrophage pyroptosis and neutrophil NETosis were detected by western blotting, live cell imaging and ELISA. Flow cytometry was used to assess the impact of spvC on macrophage-neutrophil cooperation in macrophage (dTHP-1)-neutrophil (dHL-60) co-culture model pretreated with GSDMD inhibitor disulfiram. Wild-type and Gsdmd−/− C57BL/6J mice were utilized for in vivo assay. The degree of phagocytes infiltration and inflammation were analyzed by immunofluorescence and transmission electron microscopy. Results Here we find that spvC inhibits pyroptosis in macrophages via Caspase-1/Caspase-11 dependent canonical and non-canonical pathways, and restrains neutrophil extracellular traps extrusion in GSDMD-dependent manner. Moreover, spvC could ameliorate macrophages/neutrophils infiltration and cooperation in the inflammatory response mediated by GSDMD to combat Salmonella infection. Conclusions Our findings highlight the antibacterial activity of GSDMD in phagocytes and reveal a novel pathogenic mechanism employed by spvC to counteract this host defense, which may shed new light on designing effective therapeutics to control S. Typhimurium infection. | ||
| 650 | 4 | |a Macrophage |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Neutrophil |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Gasdermin D |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Li, Yuanyuan |4 aut | |
| 700 | 1 | |a You, Jiayi |4 aut | |
| 700 | 1 | |a Wu, Chaoyi |4 aut | |
| 700 | 1 | |a Zuo, Lingli |4 aut | |
| 700 | 1 | |a Chen, Yilin |4 aut | |
| 700 | 1 | |a Kang, Li |4 aut | |
| 700 | 1 | |a Zhou, Zhengyu |4 aut | |
| 700 | 1 | |a Huang, Rui |4 aut | |
| 700 | 1 | |a Wu, Shuyan |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Inflammation research |d Cham : Springer International Publishing AG, 1969 |g 73(2023), 1 vom: 23. Dez., Seite 19-33 |w (DE-627)SPR000002968 |w (DE-600)1459194-7 |x 1420-908X |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2023 |g number:1 |g day:23 |g month:12 |g pages:19-33 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00011-023-01818-9 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2023 |e 1 |b 23 |c 12 |h 19-33 | ||